Forum Financial Management LP Acquires 5,965 Shares of Danaher Corporation $DHR

Forum Financial Management LP increased its stake in shares of Danaher Corporation (NYSE:DHR) by 212.2% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 8,776 shares of the conglomerate’s stock after acquiring an additional 5,965 shares during the period. Forum Financial Management LP’s holdings in Danaher were worth $1,944,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Main Street Group LTD acquired a new stake in Danaher in the 1st quarter valued at about $25,000. N.E.W. Advisory Services LLC bought a new stake in Danaher in the 2nd quarter valued at $25,000. Marquette Asset Management LLC boosted its position in shares of Danaher by 192.1% in the third quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 73 shares during the period. Evolution Wealth Management Inc. grew its position in shares of Danaher by 208.0% during the 1st quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 104 shares in the last quarter. Finally, Field & Main Bank acquired a new stake in Danaher during the second quarter worth approximately $29,000. 79.05% of the stock is owned by institutional investors.

Danaher Price Performance

Shares of NYSE:DHR opened at $228.87 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The stock’s 50 day moving average is $214.04 and its 200-day moving average is $195.97. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The firm has a market capitalization of $160.89 billion, a price-to-earnings ratio of 40.65, a PEG ratio of 2.91 and a beta of 0.76.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period last year, the firm earned $0.77 earnings per share. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. Sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio (DPR) is 28.42%.

Wall Street Analyst Weigh In

DHR has been the topic of a number of analyst reports. TD Cowen increased their price objective on shares of Danaher from $236.00 to $255.00 and gave the stock a “buy” rating in a research note on Tuesday. Guggenheim boosted their price objective on Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Evercore reissued an “outperform” rating and set a $230.00 target price on shares of Danaher in a report on Monday, July 6th. UBS Group initiated coverage on Danaher in a research note on Wednesday, September 9th. They issued a “buy” rating and a $250.00 price target for the company. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 price objective on shares of Danaher in a research report on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have given a Hold rating to the company. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.